Several experiments on rats prove that chronic melatonine consumption fights obesity and diabetes

October 03, 2014

Scientists at the University of Granada, in collaboration with La Paz University Hospital in Madrid and the University of Texas, San Antonio in the US have demonstrated through several experiments conducted on Zucker obese rats that chronic consumption of melatonine helps combat obesity and diabetes mellitus type two.

Their research has confirmed that chronic administration of melatonine in young obese rats with diabetes mellitus type two, similar to its human equivalent, improves mitochondrial dysfunction (i.e. mitochondrial homeostatic functions) in a very efficient way, since it improves the consumption of oxygen, it diminishes the levels of free-radicals stress and prevents the destruction of the mitochondrial membrane.

These results, published in the last issue of the prestigious Journal of Pineal Research, confirm other similar studies conducted by these researchers during the last three years.

This research has been conducted by an interdisciplinary team from the Farmacology Department and the Neuroscience Institute, University of Granada, led by prof. Ahmad Agil, with the collaboration of Dr. Gumersindo Fernández, from the Endocrinology and Nutrition Service of La Paz University Hospital in Madrid, and prof. Russell Reiter, from the Structural Biology Department at the University of Texas, in San Antonio (USA)

According to the PI, prof. Ahmad Agil, both developed and developing countries currently evince a significant increase in obesity rates and also in diabetes type two. This increase results from a maladaptation of the human genome to modern environments, sedentary lifestyles, higher consumption of hypercaloric food and excessive exposure to artificial lightning, which reduce endogenous melatonine levels.

In the case of obesity, mitochondriae (our cells' power stations) do not work properly (homeostatic imbalance) and their programmed destruction is thus accelerated (apoptosis). This leads to insuline resistance and the subsequent development of diabetes mellitus.

We must sleep in total darkness

In prof. Agil's words, melatonine "is a natural substance present in plants, animals and humans; it works as a hormonal signal released during the night to establish circadian rhythms"

Currently this process is frequently interrupted, as a result of excessive exposure to artificial lightning during the night, which reduces the levels of endogenous melatonine--for instance, many people are in the habit of sleeping with their lamps, TVs or their computers switched on, or with the blinds drawn up. "For all these reasons, it is important to try to sleep in absolute darkness, to avoid interference in the generation of melatonine".

Melatonine is a powerful antioxidant and anti-inflammatory: these properties constitute the foundation of its protective effect upon metabolism. 'Melatonine is particularly abundant in vegetables, such as spices, herbs, tea, coffee, fruit, seeds and nuts. This is one of the main reasons why these sorts of food are particularly healthy'

General treatments with specific action upon adipose tissue, and in particular upon the mitochondria, and the increase in their efficiency, could have beneficial effects upon these sorts of diseases.
This study has been funded and supported by several projects from the Ministry of Economy and Competitiveness (Spain, Ref: SAF2013-45752), the GREIB MCI-International Excellence Campus of the Vice-rectorage of Research and Scientific Policy at the University of Granada, and the CTS-109 research group (Junta de Andalucía), Spain.

University of Granada

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to